Joint Letter to Qualicaps Customers

Joint Letter to Qualicaps Customers

Effective Oct. 24, 2023

Dear Customer,

We are delighted to share a pivotal moment in the trajectory of Qualicaps that represents a significant leap forward in our ongoing commitment to deliver exceptional products and services. We are thrilled to announce the completion of the acquisition of Qualicaps by Roquette, a globally recognized and valued leader in pharmaceutical excipients. This strategic union marks a fundamental step in our dedication to advancing healthcare solutions globally. Together, we are poised to drive innovation and deliver greater value to our valued community of customers and stakeholders with an enriched product and service offering.

Roquette, established in 1933 as a family-owned private company, specializes in delivering premium plant-based ingredients to the Nutrition and Health markets. With a robust sales revenue of five billion euros in 2022, a global presence spanning over 100 countries, and a workforce exceeding 8,000 dedicated professionals, – almost 10,000 with the acquisition of Qualicaps -, Roquette stands as our ideal partner for advancing together.

Integrating Roquette and Qualicaps into a single center of activity positions us as a formidable player in the oral dosage market. Our expanded portfolio is now designed to provide you, our valued customer, with a comprehensive and diverse portfolio of solutions, ensuring an elevated level of service and fostering even more excellent prospects for future developments.

In addition, we are excited about the countless opportunities this merger provides for our dedicated employees. The pharmaceutical sector is central to Roquette’s mission, and this collaboration empowers Qualicaps employees to make significant contributions to one of Roquette’s core business objectives.

This merger is a tangible symbol of the shared commitment of both organizations to improve the quality of customer service we collectively provide. We are confident that this announcement instils confidence in our ongoing relationship with you, our valued customers.

We stand ready to address any inquiries and provide any additional information required. As we are joining together our two companies, all transactions with Qualicaps and Roquette will be as they were before, and you can continue to place orders and inquiries as you have done in the past.

Your continued support and collaboration are invaluable to us, and we look forward to embarking on this exciting journey together.

Thank you for your continued trust in Qualicaps.

Paul Smaltz
VP Pharmaceutical Solutions
Roquette

Matsumura San
CEO
Qualicaps Group